Quanterix Corporation
NASDAQ:QTRXMedical - Devices
+$0.46 today
- Market cap
- $98.28M
- Beta
- 1.12
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$2.22
Volume 3.54M
Average 1.15M
QTRX EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
Quanterix CorporationNASDAQ: QTRX
EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026
EPS (Basic) remains negative
Q1 FY2026 EPS (Basic) was -$0.37, compared with -$0.53 a year earlier. Trailing-twelve-month EPS (Basic) was -$2.36.
Context
- EPS (Basic) grew in size in 2 of the last 3 fiscal years.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 1 analysts of -$2.28 (+9.4%) for the fiscal year ending Dec 2026, a step up from the -151.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$0.37+24.5% QoQ
- Last fiscal yearDec 2025
- -$2.51-151.0% YoY
- LTMMar 2026
- -$2.36-90.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +30.2% | +46.7% | +16.5 pp |
| 1 year | -151.0% | +9.4% | +160.4 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- (2.51) USD
- Year-over-year change
- -151.0%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.51) | -151.0% |
| FY2024 | 2024-12-31 | (1.00) | -16.3% |
| FY2023 | 2023-12-31 | (0.86) | +67.0% |
| FY2022 | 2022-12-31 | (2.61) | -63.1% |
| FY2021 | 2021-12-31 | (1.60) | — |
EPS (Basic) vs competitors
How QTRX compares with its peers on the latest reported figures
- QTRX's LTM Mar 2026 EPS (Basic) of -$2.36 is the 10th highest of the 11 companies compared; the peer median is -$1.07.
- Its year-over-year change of -90.3% is the lowest of 11, against a peer median of +21.4%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $1.76 | +120.9% | — | |
| LTM Mar 2026 | $0.39 | +21.9% | +36.3% | |
| LTM Mar 2026 | -$0.71 | +27.7% | — | |
| LTM Mar 2026 | -$0.91 | +20.9% | — | |
| LTM Mar 2026 | -$0.98 | -78.2% | — | |
| LTM Dec 2025 | -$1.15 | -27.8% | — | |
| LTM Mar 2026 | -$1.17 | +40.3% | — | |
| LTM Mar 2026 | -$2.02 | +7.3% | — | |
| LTM Mar 2026 | -$2.16 | +5.7% | — | |
| LTM Mar 2026 | -$2.36 | -90.3% | — | |
| LTM Mar 2026 | -$4.16 | +87.4% | — | |
| Peer median (excluding QTRX) | -$1.07 | +21.4% | +36.3% | |
Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 110.56M | 105.52M | 121.14M | 135.44M | 138.65M |
| Cost of Revenue | 45.78M | 60.16M | 48.14M | 54.32M | 73.94M |
| Gross Profit | 64.77M | 45.36M | 73M | 81.12M | 64.72M |
| Gross Margin | 58.6% | 43.0% | 60.3% | 59.9% | 46.7% |
| Research & Development | 28.38M | 26.81M | 26.06M | 31.08M | 35.92M |
| Selling, General & Admin | 92.91M | 91.85M | 92.82M | 104.64M | 138.85M |
| Operating Expenses | 121.29M | 149.63M | 118.99M | 133.74M | 174.53M |
| Depreciation & Amortization | 4.88M | 5.41M | 8.29M | 8.36M | 18.93M |
| EBITDA | (50.3M) | (67.89M) | (36.37M) | (29.74M) | (93.35M) |
| EBITDA Margin | -45.5% | -64.3% | -30.0% | -22.0% | -67.3% |
| Operating Income | (56.52M) | (104.26M) | (45.99M) | (52.62M) | (109.82M) |
| Operating Margin | -51.1% | -98.8% | -38.0% | -38.8% | -79.2% |
| Interest Income | 0 | 5.13M | 15.84M | 14.66M | 8.57M |
| Interest Expense | 403K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 937K | 4.85M | 18.36M | 14.52M | (2.46M) |
| Income Before Tax | (55.58M) | (99.41M) | (27.64M) | (38.1M) | (112.27M) |
| Pre-Tax Margin | -50.3% | -94.2% | -22.8% | -28.1% | -81.0% |
| Income Tax Expense | (36K) | 164K | 719K | 434K | (5.12M) |
| Net Income | (55.55M) | (99.57M) | (28.35M) | (38.53M) | (107.15M) |
| Net Margin | -50.2% | -94.4% | -23.4% | -28.4% | -77.3% |
| EPS (Basic) | (1.60) | (2.61) | (0.86) | (1.00) | (2.51) |
| EPS (Diluted) | (1.60) | (2.61) | (0.86) | (1.00) | (2.51) |
| Weighted Avg Shares | 36M | 36.99M | 37.59M | 38.37M | 42.64M |
| Weighted Avg Shares (Diluted) | 36M | 36.99M | 37.59M | 38.37M | 42.64M |
Quanterix Corporation
NASDAQ:QTRX
Intrinsic Alpha fair value
Locked
Current Price
$2.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.